Vimarsana
Biggest News Aggregation in the World

Spartan Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Spartan Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Spartan Bioscience Today - Breaking & Trending Today

Health Canada ignored warning signs before Ottawa spent billions on BTNX rapid tests - National - Vimarsana News

Health Canada ignored warning signs before Ottawa spent billions on BTNX rapid tests - National

Health Canada ignored critical warnings about a rapid-test supplier before approving its COVID-19 kits for distribution nationwide, Global News has found.

Profound Medical : NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS - Form 6-K - Vimarsana News

Profound Medical : NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS - Form 6-K

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN THAT an annual and special meeting of the holders of common shares in the capital of Profound... | April 25, 2023

'Significant milestone': FDA approves Genomadix's rapid genetic-testing device for sale in U.S. – Ottawa Business Journal - Vimarsana News

'Significant milestone': FDA approves Genomadix's rapid genetic-testing device for sale in U.S. – Ottawa Business Journal

The company’s flagship product, dubbed the Genomadix Cube, is a coffee cup-sized lab-in-a-box that is engineered to extract, amplify and identify genetic material in about an hour.

Source: obj.ca
Feds Paid $106 Million for COVID Medical Supplies That Were Never Delivered - Vimarsana News

Feds Paid $106 Million for COVID Medical Supplies That Were Never Delivered

The Department of Public Works is promising to disclose what it did to verify the credibility of federal ...

Rising from Spartan's ashes: Genomadix says retooled rapid COVID test ready for market - Vimarsana News

Rising from Spartan's ashes: Genomadix says retooled rapid COVID test ready for market

Ottawa biotech startup has raised $7.5 million in fresh funding as it looks to capitalize what it says is the continued need for "a decentralized, laboratory-quality" test kit.

Source: obj.ca